Showing 1 - 2 results of 2 for search 'Linyan Zeng', query time: 0.03s Refine Results
  1. 1
    Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials

    Survival Outcomes and Safety of Programmed Cell Death/Programmed Cell Death Ligand 1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result From Phase III Trials by Linyan Zeng, Junwei Su, Wenqi Qiu, Xuehang Jin, Yunqing Qiu, Wei Yu

    Published 2022-04-01
    Get full text
    Article
  2. 2
    LAM add-on ADV combination therapy or ETV monotherapy for CHB patients with suboptimal response to ADV

    LAM add-on ADV combination therapy or ETV monotherapy for CHB patients with suboptimal response to ADV by Hongyu Jia, Feng Ding, Jianyang Chen, Yimin Zhang, Dairong Xiang, Jiangshan Lian, Linyan Zeng, Liang Yu, Jianhua Hu, Yongtao Li, Yingfeng Lu, Yuanchun Liu, Lin Zheng, Lanjuan Li, Yida Yang

    Published 2015-03-01
    Get full text
    Article

Search Tools: